COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study.
Pan H, Tang Z, Teng J, Sun Y, Liu H, Cheng X, Su Y, Ye J, Hu Q, Chi H, Zhou Z, Jia J, Meng J, Wang M, Wang F, Chen X, Ma Y, Zhang H, You Y, Zhu D, Chen L, Yang C, Shi H, Liu T.
Pan H, et al.
Rheumatology (Oxford). 2023 Feb 1;62(2):829-834. doi: 10.1093/rheumatology/keac400.
Rheumatology (Oxford). 2023.
PMID: 35866674
Free PMC article.
Notably, the distribution of the aPL profile in the pre- and post-vaccination cohorts was not affected by SARS-CoV-2 vaccination: for patients with a low-risk aPL profile (11 vs 10, P = 0.799) and patients with a high-risk aPL profile (28 vs 29, P = 0.799), respectively. Furtherm …
Notably, the distribution of the aPL profile in the pre- and post-vaccination cohorts was not affected by SARS-CoV-2 vaccination: for patien …